Recommendations for risk categorization and prophylaxis of invasive fungal diseases in hematological malignancies: A critical review of evidence and expert opinion (TEO-4)

Simple item page
dc.contributor.authorBoğa, Can
dc.contributor.authorBolaman, Zahit
dc.contributor.authorÇağırgan, Seçkin
dc.contributor.authorKaradoğan, İhsan
dc.contributor.authorÖzcan, Mehmet Ali
dc.contributor.authorSaba, Rabin
dc.contributor.authorSönmez, Mehmet
dc.contributor.authorŞenol, Esin
dc.contributor.authorAkan, Hamdi
dc.contributor.authorAkova, Murat
dc.contributor.buuauthorÖzkalemkaş, Fahir
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/İç Hastalıkları Anabilim Dalı.tr_TR
dc.contributor.researcheridAAG-8495-2021tr_TR
dc.contributor.scopusid6601912387tr_TR
dc.date.accessioned2024-02-19T12:38:38Z
dc.date.available2024-02-19T12:38:38Z
dc.date.issued2015
dc.description.abstractThis is the last of a series of articles on invasive fungal infections prepared by opinion leaders in Turkey. The aim of these articles is to guide clinicians in managing invasive fungal diseases in hematological malignancies and stem cell transplantation based on the available best evidence in this field. The previous articles summarized the diagnosis and treatment of invasive fungal disease and this article aims to explain the risk categorization and guide the antifungal prophylaxis in invasive fungal disease.en_US
dc.identifier.citationBoğa, C. vd. (2015). "Recommendations for risk categorization and prophylaxis of invasive fungal diseases in hematological malignancies: A critical review of evidence and expert opinion (TEO-4)". Turkish Journal of Hematology, 32(2), 100-117.en_US
dc.identifier.endpage117tr_TR
dc.identifier.issn1300-7777
dc.identifier.issue2tr_TR
dc.identifier.pubmed26316478tr_TR
dc.identifier.scopus2-s2.0-84930743919tr_TR
dc.identifier.startpage100tr_TR
dc.identifier.urihttps://doi.org/10.4274/tjh.2014.0277en_US
dc.identifier.urihttps://jag.journalagent.com/tjh/pdfs/TJH_32_2_100_117.pdfen_US
dc.identifier.urihttps://hdl.handle.net/11452/39853en_US
dc.identifier.volume32tr_TR
dc.identifier.wos000369116200001
dc.indexed.pubmedPubMeden_US
dc.indexed.scopusScopusen_US
dc.indexed.trdizinTrDizintr_TR
dc.indexed.wosSCIEen_US
dc.language.isoenen_US
dc.publisherGalenos Yayınları
dc.relation.collaborationYurt içitr_TR
dc.relation.collaborationSanayitr_TR
dc.relation.journalTurkish Journal of Hematologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergitr_TR
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectHematologyen_US
dc.subjectHematological malignancyen_US
dc.subjectInvasive fungal infectionsen_US
dc.subjectProphylaxisen_US
dc.subjectRisken_US
dc.subjectStem-cell transplantationen_US
dc.subjectReceiving antifungal prophylaxisen_US
dc.subjectBone-marrow-transplantationen_US
dc.subjectPlacebo-controlled trialen_US
dc.subjectDouble-blind trialen_US
dc.subjectCancer-patientsen_US
dc.subjectMold infectionsen_US
dc.subjectSingle-centeren_US
dc.subjectPulmonary aspergillosisen_US
dc.subjectFluconazole prophylaxisen_US
dc.subject.emtreeAlemtuzumaben_US
dc.subject.emtreeAmphotericin B deoxycholateen_US
dc.subject.emtreeAmphotericin B lipid complexen_US
dc.subject.emtreeAnidulafunginen_US
dc.subject.emtreeAnthracyclineen_US
dc.subject.emtreeCaspofunginen_US
dc.subject.emtreeCell surface proteinen_US
dc.subject.emtreeCorticosteroiden_US
dc.subject.emtreeCytochrome P450 isoenzymeen_US
dc.subject.emtreeDiphtheria toxoid CRM197en_US
dc.subject.emtreeEchinocandinen_US
dc.subject.emtreeFluconazoleen_US
dc.subject.emtreeFructose bisphosphate aldolaseen_US
dc.subject.emtreeGlucan glucosidaseen_US
dc.subject.emtreeGlucuronoxylomannanen_US
dc.subject.emtreeItraconazoleen_US
dc.subject.emtreeLaminaranen_US
dc.subject.emtreeMalate dehydrogenaseen_US
dc.subject.emtreeMannanen_US
dc.subject.emtreeMicafunginen_US
dc.subject.emtreePlaceboen_US
dc.subject.emtreePosaconazoleen_US
dc.subject.emtreeRapamycinen_US
dc.subject.emtreeRecombinant proteinen_US
dc.subject.emtreeRituximaben_US
dc.subject.emtreeSignaling lymphocyte activation molecule associated proteinen_US
dc.subject.emtreeTriazoleen_US
dc.subject.emtreeUnindexed drugen_US
dc.subject.emtreeVincristineen_US
dc.subject.emtreeVoriconazoleen_US
dc.subject.emtreeAntifungal agenten_US
dc.subject.emtreeAntineoplastic agenten_US
dc.subject.emtreeImmunosuppressive agenten_US
dc.subject.emtreeAcute myeloblastic leukemiaen_US
dc.subject.emtreeAllogeneic stem cell transplantationen_US
dc.subject.emtreeCryptococcosisen_US
dc.subject.emtreeDisease associationen_US
dc.subject.emtreeDrug monitoringen_US
dc.subject.emtreeGraft versus host reactionen_US
dc.subject.emtreeHematologic malignancyen_US
dc.subject.emtreeHumanen_US
dc.subject.emtreeInfection risken_US
dc.subject.emtreeInvasive aspergillosisen_US
dc.subject.emtreeInvasive candidiasisen_US
dc.subject.emtreeMass spectrometryen_US
dc.subject.emtreeMeta analysis (topic)en_US
dc.subject.emtreeMycosisen_US
dc.subject.emtreeMyelodysplastic syndromeen_US
dc.subject.emtreeRandomized controlled trial (topic)en_US
dc.subject.emtreeReviewen_US
dc.subject.emtreeRisk assessmenten_US
dc.subject.emtreeTreatment outcomeen_US
dc.subject.emtreeAdverse effectsen_US
dc.subject.emtreeBlooden_US
dc.subject.emtreeChemically induceden_US
dc.subject.emtreeComplicationen_US
dc.subject.emtreeCross infectionen_US
dc.subject.emtreeDisinfectionen_US
dc.subject.emtreeFebrile neutropeniaen_US
dc.subject.emtreeHematologic neoplasmsen_US
dc.subject.emtreeImmunocompromised patienten_US
dc.subject.emtreeInvasive fungal infectionsen_US
dc.subject.emtreeOpportunistic infectionsen_US
dc.subject.emtreePractice guidelineen_US
dc.subject.emtreeProceduresen_US
dc.subject.emtreeSecondary preventionen_US
dc.subject.emtreeTransplantation conditioningen_US
dc.subject.meshAntifungal agentsen_US
dc.subject.meshAntineoplastic agentsen_US
dc.subject.meshCross infectionen_US
dc.subject.meshDisinfectionen_US
dc.subject.meshFebrile neutropeniaen_US
dc.subject.meshHematologic neoplasmsen_US
dc.subject.meshHumansen_US
dc.subject.meshImmunocompromised hosten_US
dc.subject.meshImmunosuppressive agentsen_US
dc.subject.meshInvasive fungal infectionsen_US
dc.subject.meshOpportunistic infectionsen_US
dc.subject.meshPractice guidelines as topicen_US
dc.subject.meshRisk assessmenten_US
dc.subject.meshSecondary preventionen_US
dc.subject.meshTransplantation conditioningen_US
dc.subject.scopusAntifungal agents; Posaconazole; Micafunginen_US
dc.subject.wosHematologyen_US
dc.titleRecommendations for risk categorization and prophylaxis of invasive fungal diseases in hematological malignancies: A critical review of evidence and expert opinion (TEO-4)en_US
dc.title.alternativeHematolojik malignitelerdeki invazif fungal enfeksiyon riskinin belirlenmesi ve profilaksi: Kanıtlara eleştirel bakış ve Türk uzman görüşleri (TUG-4)en_US
dc.typeArticleen_US
dc.wos.quartileQ4en_US

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Özkalemkaş_vd_2015.pdf
Size:
247.72 KB
Format:
Adobe Portable Document Format
Description:
Download

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Web of Science